• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EV3 NEUROVASCULAR SOLITAIRE FR; FLOW RESTORATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EV3 NEUROVASCULAR SOLITAIRE FR; FLOW RESTORATION Back to Search Results
Model Number SFR-4-20
Device Problem Physical Resistance (2578)
Patient Problems Death (1802); Hemorrhage, Cerebral (1889); Reocclusion (1985)
Event Date 07/14/2014
Event Type  Death  
Event Description
Treatment of an acute stroke.The anatomy of the patient was medium in tortuosity and the vessels were narrow.On (b)(6) 2014, the patient underwent mechanical thrombectomy.During the procedure, it was reported the solitaire was delivered to the m1/m2 and retrieved after ten minutes.Thrombus was retrieved; however, there was more to be removed.Another pass was made to retrieve more thrombus and after 5 minutes, the physician confirmed the vessel was revascularized and decided to remove the device from the patient.Upon retrieving the device, slight resistance was experienced, but this resistance was also experienced during the retrieval of the device the first time so the physician continued retrieving the device.Shortly after, the resistance was no longer felt and the stent detached from the proximal marker.Due to stent detaching from the proximal marker and not being visible through angiography, it was decided to use another device (penumbra 4 max) to continue with the thrombectomy for the third time in the same vessel.The thrombus received this time was very small.The physician waited 10 minutes in order to monitor the condition; however, the vessel re-occluded from the distal m1 due to the remaining thrombus.For this reason, it was decided to use a coronary stent to capture the thrombus, but failed because the catheter could not be delivered to the target area.Spasm was confirmed at the area of the detached solitaire stent, but the physician confirmed the vessel was revascularized and the procedure was completed.The patient's symptom of agnosia was also improving and the patient was transferred to the icu (intensive care unit) at 22:15 and started antihypertensive therapy and antithrombocyte oral therapy.On (b)(6) 2014, the patient expired.Ct (computed tomography) revealed a hemorrhage due to the basal ganglia and it was decided that the hemorrhage was related to the primary disease.
 
Manufacturer Narrative
The device involved in the event will not be returned for evaluation as it remains in the patient.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SOLITAIRE FR
Type of Device
FLOW RESTORATION
Manufacturer (Section D)
EV3 NEUROVASCULAR
9775 toledo way
irvine CA 92618
Manufacturer Contact
michael nguyen
9775 toledo way
irvine, CA 92618
9496801558
MDR Report Key4037011
MDR Text Key15817533
Report Number2029214-2014-00482
Device Sequence Number1
Product Code NRY
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Health Professional,User Facility
Reporter Occupation Physician
Type of Report Initial
Report Date 07/16/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/14/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/06/2016
Device Model NumberSFR-4-20
Device Lot Number9866915
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/16/2014
Was Device Evaluated by Manufacturer? No
Date Device Manufactured02/08/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Disability;
Patient Age80 YR
-
-